THIRD AMENDMENT TO THE LICENSE AGREEMENT OF SEPTEMBER 20, 2013License Agreement • February 20th, 2024 • Tenax Therapeutics, Inc. • Pharmaceutical preparations
This Third Amendment to the License Agreement of September 20, 2013 (hereinafter referred to as the “Amendment”) is made and executed as of this 19th day of February, 2024 (“Effective Date of Amendment”) by and between:
